All Updates

All Updates

icon
Filter
Management news
Genentech to lay off 93 employees in San Francisco among restructuring efforts
Longevity Tech
Aug 28, 2024
This week:
Partnerships
T-Mobile partners with OpenAI to develop AI-powered customer service platform
Generative AI Applications
Today
Partnerships
Runway partners with Lionsgate to develop AI video tools using studio's movie catalog
Generative AI Applications
Yesterday
Funding
QMill raises EUR 4 million in seed funding to provide quantum computing industrial applications
Quantum Computing
Yesterday
Product updates
QuiX Quantum launches 'Bia' quantum cloud computing service for quantum solutions
Quantum Computing
Yesterday
Partnerships
Oxford Ionics and Infineon Technologies partner to build portable quantum computer for Cyberagentur
Quantum Computing
Yesterday
Product updates
Partnerships
Tencent Ai Lab launches EzAudio AI for text-to-audio generation with Johns Hopkins University
Foundation Models
Yesterday
Funding
TON secures USD 30 million in investment from Bitget and Foresight Ventures
Web3 Ecosystem
Yesterday
Funding
Hemi Labs raises USD 15 million in funding to launch blockchain network
Web3 Ecosystem
Yesterday
Product updates
Fivetran launches Hybrid Deployment for data pipeline management
Machine Learning Infrastructure
Yesterday
Product updates
Fivetran launches Hybrid Deployment for data pipeline management
Data Infrastructure & Analytics
Yesterday
Longevity Tech

Longevity Tech

Aug 28, 2024

Genentech to lay off 93 employees in San Francisco among restructuring efforts

Management news

  • Genentech will lay off 93 employees at its South San Francisco headquarters effective October 8, 2024. The layoffs will primarily impact scientists, engineers, managers, analysts, and one vice president.

  • The announcement follows the recent closure of Genentech's cancer immunology group as the company shifts focus within its cancer research investments. A spokesperson previously stated that this decision was due to changes in the science of immuno-oncology, leading to the integration of cancer immunology research with molecular oncology programs.

  • This marks Genentech's second round of layoffs in 2024. In April, the company reduced its workforce by approximately 3%, affecting over 400 positions across multiple departments. However, no job cuts were reported at its parent company, Roche.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.